Jane Street’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-88,921
| Closed | -$942K | – | 5391 |
|
2025
Q1 | $942K | Sell |
88,921
-7,031
| -7% | -$74.5K | ﹤0.01% | 3135 |
|
2024
Q4 | $1.63M | Buy |
95,952
+36,150
| +60% | +$613K | ﹤0.01% | 2344 |
|
2024
Q3 | $1.39M | Sell |
59,802
-13,310
| -18% | -$309K | ﹤0.01% | 2924 |
|
2024
Q2 | $1.78M | Buy |
73,112
+25,295
| +53% | +$616K | ﹤0.01% | 2889 |
|
2024
Q1 | $1.61M | Sell |
47,817
-23,539
| -33% | -$795K | ﹤0.01% | 2586 |
|
2023
Q4 | $2.25M | Sell |
71,356
-7,608
| -10% | -$240K | ﹤0.01% | 2361 |
|
2023
Q3 | $2.02M | Buy |
78,964
+27,944
| +55% | +$714K | ﹤0.01% | 2231 |
|
2023
Q2 | $1.46M | Buy |
51,020
+1,702
| +3% | +$48.8K | ﹤0.01% | 2712 |
|
2023
Q1 | $1.18M | Sell |
49,318
-36,024
| -42% | -$863K | ﹤0.01% | 2630 |
|
2022
Q4 | $1.45M | Buy |
85,342
+54,290
| +175% | +$921K | ﹤0.01% | 2292 |
|
2022
Q3 | $461K | Sell |
31,052
-5,876
| -16% | -$87.2K | ﹤0.01% | 3704 |
|
2022
Q2 | $581K | Buy |
36,928
+23,519
| +175% | +$370K | ﹤0.01% | 3395 |
|
2022
Q1 | $362K | Sell |
13,409
-28,144
| -68% | -$760K | ﹤0.01% | 4101 |
|
2021
Q4 | $1.54M | Sell |
41,553
-13,745
| -25% | -$509K | ﹤0.01% | 2223 |
|
2021
Q3 | $2.64M | Buy |
55,298
+29,748
| +116% | +$1.42M | ﹤0.01% | 1539 |
|
2021
Q2 | $865K | Buy |
+25,550
| New | +$865K | ﹤0.01% | 2788 |
|
2021
Q1 | – | Sell |
-86,826
| Closed | -$3.77M | – | 4925 |
|
2020
Q4 | $3.77M | Sell |
86,826
-66,730
| -43% | -$2.89M | ﹤0.01% | 914 |
|
2020
Q3 | $6.59M | Buy |
153,556
+65,468
| +74% | +$2.81M | ﹤0.01% | 485 |
|
2020
Q2 | $4.12M | Buy |
88,088
+69,761
| +381% | +$3.26M | ﹤0.01% | 810 |
|
2020
Q1 | $249K | Buy |
+18,327
| New | +$249K | ﹤0.01% | 2721 |
|
2014
Q4 | – | Sell |
-2,101
| Closed | -$227K | – | 1791 |
|
2014
Q3 | $227K | Buy |
+2,101
| New | +$227K | ﹤0.01% | 1781 |
|